Lessons learned from COVID-19 to overcome challenges in conducting outpatient clinical trials to find safe and effective therapeutics for the next infectious pandemic
J Clin Transl Sci
.
2024 Oct 15;8(1):e153.
doi: 10.1017/cts.2024.607.
eCollection 2024.
Authors
Minn A Oh
1
,
Judith Currier
2
,
Akram Khan
1
,
Eleftherios Mylonakis
3
,
Matthew Newell
4
,
Rachel Bender Ignacio
5
,
Nick Jilg
6
,
Basmah Safdar
7
,
Lisa H Merck
8
,
Davey M Smith
9
Affiliations
1
Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
2
Department of Medicine, University of California, Los Angeles, CA, USA.
3
Department of Medicine, Houston Methodist Hospital, Houston, TX, USA.
4
Global Health and Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
5
Department of Medicine, University of Washington, Seattle, WA, USA.
6
Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital, Boston, MA, USA.
7
Department of Emergency Medicine, Yale University, New Haven, CT, USA.
8
Department of Energy Medicine, Virginia Commonwealth, Richmond, VA, USA.
9
Altman Clinical and Translational Research Institute, University of California, San Diego, CA, USA.
PMID:
39540115
PMCID:
PMC11557272
DOI:
10.1017/cts.2024.607
No abstract available
Publication types
Editorial